Company profile
Black Diamond Therapeutics, Inc. Insider Trading
BDTXEvery SEC Form 4 insider trading filing for Black Diamond Therapeutics, Inc. (BDTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001701541
- Filings
- 83
- Insiders
- 26
- Last filing
- 2026-06-26
Activity summary
No insider transactions in the last 30 days. The most recent was on June 26, 2026, when Campbell Shannon bought 40,000 shares. 83 filings from 26 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Black Diamond Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $12.0M.
90 day insight
Over the last 90 days, Black Diamond Therapeutics, Inc. insiders bought $28K across 8 transactions with no open-market sales.
- Most active insider: Behbahani Ali with 2 transactions totaling $15K.
- Largest single purchase: $15K by Behbahani Ali on Jun 19, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Campbell Shannon | BDTX | Award | 40,000 | — | — |
| Jun 26, 2026 | Behbahani Ali | BDTX | Award | 40,000 | — | — |
| Jun 26, 2026 | Menzel Garry E | BDTX | Award | 40,000 | — | — |
| Jun 26, 2026 | Kulkarni Samarth | BDTX | Award | 40,000 | — | — |
| Jun 26, 2026 | Raman Prakash | BDTX | Award | 40,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=BDTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Black Diamond Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →